DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Greenberg BM, Rodriquez M, Kantarci O , et al.
Safety and tolerability of remyelinating therapeutic antibody rHIgM22 in patients with stable multiple sclerosis.
Poster presented at: 67th American Academy of Neurology Annual Meeting; April 18–25, 2015; Washington, DC
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.